Influencia de un escáner de mesa, usado para digitalizar, en la determinación de dosis por película radiocrómica

Introduction: The precision in determination of the dose using radiochromic films as a dosimeter is influenced by three main aspects: the dose delivery capacity of the radiation unit, the response of the film when exposed to radiation, and the capacity of the scanner to digitize the films and transform them into intensity values. This work focuses on the last aspect. Objective: To establish a methodology for the evaluation of the variability of the dose due to the repeatability of scans and the position of the film in the scanning area, under calibration conditions of radiochromic films for three different resolutions. Methods: Pieces of EBT3 radiochromic films were irradiated at 11 different dose values, which were scanned at 3 different resolutions, creating a calibration curve for each resolution. These curves are used to determine dose variations due to film position in the scan area and scan repeatability; for this purpose, we measured 5 dose values per film, for each of 9 images by resolution, with a total of 27 images. Results: In the three resolutions studied, uncertainties below 1% were found due to variation in the position of the film in the scanning area and uncertainty below 2% in the case of scan repeatability. Conclusions: The values obtained from the sources of uncertainty studied were not negligible; therefore, they must be included in the total uncertainty budget of the radiochromic film dose measurement process. Working with dose values eliminates the dependence on the resolution.Introducción: La precisión en la determinación de la dosis utilizando películas radiocrómicas como dosímetro, se encuentra influenciada por: la capacidad del equipo emisor de radiación ionizante al dar la dosis deseada, la respuesta de la película al ser expuesta a la radiación y a la capacidad del escáner para digitalizar las películas y transformarlas en valores de intensidad. Este trabajo se enfoca en este último aspecto. Objetivo: Establecer una metodología para la evaluación de la variabilidad de la dosis debido a la repetibilidad de escaneos y a la posición de la película en el área de escaneo, en condiciones de calibración de las películas radiocrómicas para tres resoluciones distintas. Métodos: Irradiamos piezas de películas radiocrómicas EBT3 a 11 valores diferentes de dosis, las cuales escaneamos a tres resoluciones diferentes, creando una curva de calibración para cada resolución. Estas curvas se utilizan para determinar las variaciones en la dosis debido a la posición de la película en el área de escaneo y a la repetibilidad de escaneo; lo anterior, a partir de cinco valores de dosis medidos por película, para cada una de las nueve imágenes tomadas por resolución, siendo en total 27 imágenes. Resultados: Para las tres resoluciones estudiadas, determinamos: las curvas de calibración, incertidumbres por debajo del 1% debido a la variación de la posición de la película en el área de escaneo e incertidumbre por debajo del 2% para el caso de repetibilidad de escaneos. Conclusión: Los valores obtenidos de las fuentes de incertidumbre no fueron despreciables: deben incluirse en el presupuesto total de incertidumbre de la medición. Al usar valores de dosi,s y no intensidad o densidad óptica, se elimina la dependencia de la resolución

Dose-effect calibration curve for high X-ray doses using the Calyculin-A chromosome premature condensation assay

Purpose: This article shows the results of the Cytogenetics Laboratory of the Health Research Institute (INISA) to develop a dose-effect calibration curve with the Calyculin-A chemical induction premature condensation assay to estimate high doses of X-ray exposure. Methods: to create the calibration curve, peripheral blood samples from two participants (one female and one male) were exposed to X-rays at six different dose points ranging from 0 to 17.5 Gy in vitro. The irradiated blood was cultured for 48 hours according to international protocols, and the resulting chromosome rings were recorded. We used BioDoseTools software to calculate the coefficients for the calibration curve. Results: The coefficients of the curve are α: 0.028±0.001 and C: 0.001±0.001. These coefficients have similar values to those reported internationally. The curve was validated by calculating an unknown dose exposed to 6 Gy; the estimated dose was 5.651 ± 0.636 Gy, with no statistically significant differences between the dose delivered and the estimated dose. Conclusions: The INISA Biological Dosimetry Service can use the curve obtained to assess absorbed doses in cases of suspected overexposure to high X-ray doses

Impact of COVID-19 on cardiovascular testing in the United States versus the rest of the world

Objectives: This study sought to quantify and compare the decline in volumes of cardiovascular procedures between the United States and non-US institutions during the early phase of the coronavirus disease-2019 (COVID-19) pandemic. Background: The COVID-19 pandemic has disrupted the care of many non-COVID-19 illnesses. Reductions in diagnostic cardiovascular testing around the world have led to concerns over the implications of reduced testing for cardiovascular disease (CVD) morbidity and mortality. Methods: Data were submitted to the INCAPS-COVID (International Atomic Energy Agency Non-Invasive Cardiology Protocols Study of COVID-19), a multinational registry comprising 909 institutions in 108 countries (including 155 facilities in 40 U.S. states), assessing the impact of the COVID-19 pandemic on volumes of diagnostic cardiovascular procedures. Data were obtained for April 2020 and compared with volumes of baseline procedures from March 2019. We compared laboratory characteristics, practices, and procedure volumes between U.S. and non-U.S. facilities and between U.S. geographic regions and identified factors associated with volume reduction in the United States. Results: Reductions in the volumes of procedures in the United States were similar to those in non-U.S. facilities (68% vs. 63%, respectively; p = 0.237), although U.S. facilities reported greater reductions in invasive coronary angiography (69% vs. 53%, respectively; p < 0.001). Significantly more U.S. facilities reported increased use of telehealth and patient screening measures than non-U.S. facilities, such as temperature checks, symptom screenings, and COVID-19 testing. Reductions in volumes of procedures differed between U.S. regions, with larger declines observed in the Northeast (76%) and Midwest (74%) than in the South (62%) and West (44%). Prevalence of COVID-19, staff redeployments, outpatient centers, and urban centers were associated with greater reductions in volume in U.S. facilities in a multivariable analysis. Conclusions: We observed marked reductions in U.S. cardiovascular testing in the early phase of the pandemic and significant variability between U.S. regions. The association between reductions of volumes and COVID-19 prevalence in the United States highlighted the need for proactive efforts to maintain access to cardiovascular testing in areas most affected by outbreaks of COVID-19 infection

Can Chlorophyll a Fluorescence and Photobleaching Be a Stress Signal under Abiotic Stress in Vigna unguiculata L.?

Greenhouse gas emissions continue raising the planet&rsquo;s temperature by 1.5 &deg;C since the industrial age, while the world population growth rate is 1.1%. So, studies aimed at food security and better land use are welcomed. In this paradigm, we choose Vigna unguiculata to test how it would behave in the face of severe abiotic stresses, such as drought and salt stress. This study shows that under abiotic stresses V. unguiculata tries to overcome the stress by emitting chlorophyll a fluorescence and promoting photobleaching. Thus, fewer photons are directed to photosystem I, to generate lethal reactive oxygen species. The antioxidant system showed a high activity in plants submitted to drought stress but fell in salt-stressed plants. Thus, the reductor power not dissipated by fluorescence or heat was captured and converted into hydrogen peroxide (H2O2) which was 2.2-fold higher in salt-stressed V. unguiculata plants. Consequently, the malondialdehyde (MDA) increased in all treatment. Compiling all data, we can argue that the rapid extinguishing of chlorophyll a fluorescence, mainly in non-photochemical quenching and heat can be an indicator of stress as a first defense system, while the H2O2 and MDA accumulation would be considered biochemical signals for plant defenses or plant injuries

Can Chlorophyll a Fluorescence and Photobleaching Be a Stress Signal under Abiotic Stress in <i>Vigna unguiculata</i> L.?

Greenhouse gas emissions continue raising the planet’s temperature by 1.5 °C since the industrial age, while the world population growth rate is 1.1%. So, studies aimed at food security and better land use are welcomed. In this paradigm, we choose Vigna unguiculata to test how it would behave in the face of severe abiotic stresses, such as drought and salt stress. This study shows that under abiotic stresses V. unguiculata tries to overcome the stress by emitting chlorophyll a fluorescence and promoting photobleaching. Thus, fewer photons are directed to photosystem I, to generate lethal reactive oxygen species. The antioxidant system showed a high activity in plants submitted to drought stress but fell in salt-stressed plants. Thus, the reductor power not dissipated by fluorescence or heat was captured and converted into hydrogen peroxide (H2O2) which was 2.2-fold higher in salt-stressed V. unguiculata plants. Consequently, the malondialdehyde (MDA) increased in all treatment. Compiling all data, we can argue that the rapid extinguishing of chlorophyll a fluorescence, mainly in non-photochemical quenching and heat can be an indicator of stress as a first defense system, while the H2O2 and MDA accumulation would be considered biochemical signals for plant defenses or plant injuries

Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

Background: In early 2020, COVID-19 massively hit Italy, earlier and harder than any other European country. This caused a series of strict containment measures, aimed at blocking the spread of the pandemic. Healthcare delivery was also affected when resources were diverted towards care of COVID-19 patients, including intensive care wards. Aim of the study: The aim is assessing the impact of COVID-19 on cardiac imaging in Italy, compare to the Rest of Europe (RoE) and the World (RoW). Methods: A global survey was conducted in May–June 2020 worldwide, through a questionnaire distributed online. The survey covered three periods: March and April 2020, and March 2019. Data from 52 Italian centres, a subset of the 909 participating centres from 108 countries, were analyzed. Results: In Italy, volumes decreased by 67% in March 2020, compared to March 2019, as opposed to a significantly lower decrease (p &lt; 0.001) in RoE and RoW (41% and 40%, respectively). A further decrease from March 2020 to April 2020 summed up to 76% for the North, 77% for the Centre and 86% for the South. When compared to the RoE and RoW, this further decrease from March 2020 to April 2020 in Italy was significantly less (p = 0.005), most likely reflecting the earlier effects of the containment measures in Italy, taken earlier than anywhere else in the West. Conclusions: The COVID-19 pandemic massively hit Italy and caused a disruption of healthcare services, including cardiac imaging studies. This raises concern about the medium- and long-term consequences for the high number of patients who were denied timely diagnoses and the subsequent lifesaving therapies and procedures

Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

Objectives: The INCAPS COVID Oceania study aimed to assess the impact caused by the COVID-19 pandemic on cardiac procedure volume provided in the Oceania region. Methods: A retrospective survey was performed comparing procedure volumes within March 2019 (pre-COVID-19) with April 2020 (during first wave of COVID-19 pandemic). Sixty-three (63) health care facilities within Oceania that perform cardiac diagnostic procedures were surveyed, including a mixture of metropolitan and regional, hospital and outpatient, public and private sites, and 846 facilities outside of Oceania. The percentage change in procedure volume was measured between March 2019 and April 2020, compared by test type and by facility. Results: In Oceania, the total cardiac diagnostic procedure volume was reduced by 52.2% from March 2019 to April 2020, compared to a reduction of 75.9% seen in the rest of the world (p&lt;0.001). Within Oceania sites, this reduction varied significantly between procedure types, but not between types of health care facility. All procedure types (other than stress cardiac magnetic resonance [CMR] and positron emission tomography [PET]) saw significant reductions in volume over this time period (p&lt;0.001). In Oceania, transthoracic echocardiography (TTE) decreased by 51.6%, transoesophageal echocardiography (TOE) by 74.0%, and stress tests by 65% overall, which was more pronounced for stress electrocardiograph (ECG) (81.8%) and stress echocardiography (76.7%) compared to stress single-photon emission computerised tomography (SPECT) (44.3%). Invasive coronary angiography decreased by 36.7% in Oceania. Conclusion: A significant reduction in cardiac diagnostic procedure volume was seen across all facility types in Oceania and was likely a function of recommendations from cardiac societies and directives from government to minimise spread of COVID-19 amongst patients and staff. Longer term evaluation is important to assess for negative patient outcomes which may relate to deferral of usual models of care within cardiology

International Impact of COVID-19 on the Diagnosis of Heart Disease

Background: The coronavirus disease 2019 (COVID-19) pandemic has adversely affected diagnosis and treatment of noncommunicable diseases. Its effects on delivery of diagnostic care for cardiovascular disease, which remains the leading cause of death worldwide, have not been quantified. Objectives: The study sought to assess COVID-19's impact on global cardiovascular diagnostic procedural volumes and safety practices. Methods: The International Atomic Energy Agency conducted a worldwide survey assessing alterations in cardiovascular procedure volumes and safety practices resulting from COVID-19. Noninvasive and invasive cardiac testing volumes were obtained from participating sites for March and April 2020 and compared with those from March 2019. Availability of personal protective equipment and pandemic-related testing practice changes were ascertained. Results: Surveys were submitted from 909 inpatient and outpatient centers performing cardiac diagnostic procedures, in 108 countries. Procedure volumes decreased 42% from March 2019 to March 2020, and 64% from March 2019 to April 2020. Transthoracic echocardiography decreased by 59%, transesophageal echocardiography 76%, and stress tests 78%, which varied between stress modalities. Coronary angiography (invasive or computed tomography) decreased 55% (p &lt; 0.001 for each procedure). In multivariable regression, significantly greater reduction in procedures occurred for centers in countries with lower gross domestic product. Location in a low-income and lower–middle-income country was associated with an additional 22% reduction in cardiac procedures and less availability of personal protective equipment and telehealth. Conclusions: COVID-19 was associated with a significant and abrupt reduction in cardiovascular diagnostic testing across the globe, especially affecting the world's economically challenged. Further study of cardiovascular outcomes and COVID-19–related changes in care delivery is warranted